Samyang Holdings will spin off its BioPharm division to form Samyang Biopharm, with a 9:1 split ratio, aiming for a November KOSPI listing and enhanced biotech focus.
#YonhapInfomax #SamyangHoldings #SamyangBiopharm #Demerger #KOSPIListing #PharmaceuticalBusiness #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65639